These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15023148)

  • 61. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
    Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 63. ABO-Incompatible Kidney Transplantation After Bone Marrow Transplantation: A Case Report.
    Kosoku A; Uchida J; Shimada H; Kabei K; Nishide S; Iwai T; Nakatani T
    Transplant Proc; 2020 Nov; 52(9):2754-2757. PubMed ID: 32586664
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Kinetics of cellular and humoral immunity in a successful case of positive crossmatch kidney transplantation: a case report.
    Tanimine N; Ide K; Yamashita M; Tanaka Y; Igarashi Y; Banshodani M; Tazawa H; Basnet NB; Doskali M; Onoe T; Tashiro H; Ohdan H
    Transplant Proc; 2011; 43(6):2411-4. PubMed ID: 21839279
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative study of theefficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis.
    Kobayashi T; Yokoyama I; Morozumi K; Nagasaka T; Hayashi S; Uchida K; Takagi H; Nakao A
    Xenotransplantation; 2000 May; 7(2):101-8. PubMed ID: 10961294
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical outcome of living donor kidney transplantation across simultaneous ABO and HLA incompatibility: Single center experience of first ten cases.
    Pandey P; Setya D; Devra AK; Sinha VK; Bhatt AP; Pande A; Kumar P; Singh MK; Ranjan S
    Transfus Apher Sci; 2021 Feb; 60(1):102954. PubMed ID: 33008743
    [TBL] [Abstract][Full Text] [Related]  

  • 68. ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab.
    Chikaraishi T; Sasaki H; Tsutsumi H; Miyano S; Nakazawa R; Nakano T; Kitajima K; Kudo H; Takahashi T; Sato Y; Kimura K
    Transplant Proc; 2008 Dec; 40(10):3445-7. PubMed ID: 19100409
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.
    Stegall MD; Gloor J; Winters JL; Moore SB; Degoey S
    Am J Transplant; 2006 Feb; 6(2):346-51. PubMed ID: 16426319
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.
    Klein K; Süsal C; Schäfer SM; Becker LE; Beimler J; Schwenger V; Zeier M; Schemmer P; Macher-Goeppinger S; Scherer S; Opelz G; Morath C
    Atheroscler Suppl; 2013 Jan; 14(1):199-202. PubMed ID: 23357165
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Double-Filtration Plasmapheresis Plus Low-Dose Anti-thymocyte Globulin and Tacrolimus in Asian Living-Donor Kidney Transplantation With Donor-Specific Anti-HLA Antibody.
    Kantachuvesiri S; Ingsathit A; Thammanichanond D; Choochaeam K; Sra-Ium S; Kitiyakara C; Nongnuch A; Sakulchairungrueng B; Worawichawong S
    Transplant Proc; 2021 Apr; 53(3):995-1000. PubMed ID: 32948312
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Kidney paired donation in the presence of donor-specific antibodies.
    Blumberg JM; Gritsch HA; Reed EF; Cecka JM; Lipshutz GS; Danovitch GM; McGuire S; Gjertson DW; Veale JL
    Kidney Int; 2013 Nov; 84(5):1009-16. PubMed ID: 23715120
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period.
    Kohei N; Hirai T; Omoto K; Ishida H; Tanabe K
    Am J Transplant; 2012 Feb; 12(2):469-76. PubMed ID: 22054413
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A case report of successful renal transplantation in an ABO incompatible patient with a preformed donor-specific antibody and negative CDC human leukocyte antigens crossmatch.
    Chowdhry M; Makroo RN; Kakkar B; Jasuja S; Sagar G; Thakur Y
    Saudi J Kidney Dis Transpl; 2018; 29(3):698-704. PubMed ID: 29970748
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ABO incompatible renal transplantation in an HIV-seropositive patient.
    Campara M; West-Thielke P; Thielke J; Ommert T; Oberholzer J; Benedetti E; Kaplan B
    Transplantation; 2008 Jul; 86(1):176-8. PubMed ID: 18622297
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Desensitization with plasmapheresis and anti-Cd20 for ABO incompatible kidney transplantation from living donor: experience of a single center in Italy.
    Silvestre C; Furian L; Marson P; Tison T; Valente M; Marchini F; Rossi B; Bonfante L; Valerio F; Cozzi E; Rigotti P
    Transplant Proc; 2014 Sep; 46(7):2209-13. PubMed ID: 25242753
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Short-Term Outcomes of ABO-Incompatible Living Donor Kidney Transplantation With Uniform Protocol: Significance of Baseline Anti-ABO Titer.
    Lee KW; Park JB; Oh DK; Na BG; Choi JY; Cho WT; Lee SH; Park HJ; Cho D; Huh WS; Kim SJ
    Transplant Proc; 2016 Apr; 48(3):820-6. PubMed ID: 27234744
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Case report: Eculizumab rescue of severe accelerated antibody-mediated rejection after ABO-incompatible kidney transplant.
    Stewart ZA; Collins TE; Schlueter AJ; Raife TI; Holanda DG; Nair R; Reed AI; Thomas CP
    Transplant Proc; 2012 Dec; 44(10):3033-6. PubMed ID: 23195021
    [TBL] [Abstract][Full Text] [Related]  

  • 79. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience.
    Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P
    Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acute humoral rejection of kidney allografts in patients with a positive flow cytometry crossmatch (FCXM).
    Takeda A; Uchida K; Haba T; Tominaga Y; Katayama A; Kobayashi T; Oikawa T; Morozumi K
    Clin Transplant; 2000; 14 Suppl 3():15-20. PubMed ID: 11092347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.